Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells

View ORCID ProfileHussin A. Rothan, Shannon Stone, Janhavi Natekar, Pratima Kumari, Komal Arora, View ORCID ProfileMukesh Kumar
doi: https://doi.org/10.1101/2020.04.14.041228
Hussin A. Rothan
1Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hussin A. Rothan
  • For correspondence: hrothan@gsu.edu mkumar8@gsu.edu
Shannon Stone
1Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janhavi Natekar
1Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pratima Kumari
1Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Komal Arora
1Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mukesh Kumar
1Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mukesh Kumar
  • For correspondence: hrothan@gsu.edu mkumar8@gsu.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2020.04.14.041228
History 
  • April 15, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Hussin A. Rothan1,*,
  2. Shannon Stone1,
  3. Janhavi Natekar1,
  4. Pratima Kumari1,
  5. Komal Arora and
  6. Mukesh Kumar1,*
  1. 1Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
  1. ↵*Corresponding author: Hussin A. Rothan and Mukesh Kumar, Department of Biology, College of Arts and Sciences, Georgia State University, 145 Piedmont Ave SE, Atlanta, GA 30303. Email: hrothan{at}gsu.edu; mkumar8{at}gsu.edu.
Back to top
PreviousNext
Posted April 15, 2020.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
Hussin A. Rothan, Shannon Stone, Janhavi Natekar, Pratima Kumari, Komal Arora, Mukesh Kumar
bioRxiv 2020.04.14.041228; doi: https://doi.org/10.1101/2020.04.14.041228
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
Hussin A. Rothan, Shannon Stone, Janhavi Natekar, Pratima Kumari, Komal Arora, Mukesh Kumar
bioRxiv 2020.04.14.041228; doi: https://doi.org/10.1101/2020.04.14.041228

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Microbiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4119)
  • Biochemistry (8828)
  • Bioengineering (6532)
  • Bioinformatics (23484)
  • Biophysics (11805)
  • Cancer Biology (9223)
  • Cell Biology (13336)
  • Clinical Trials (138)
  • Developmental Biology (7442)
  • Ecology (11425)
  • Epidemiology (2066)
  • Evolutionary Biology (15173)
  • Genetics (10453)
  • Genomics (14056)
  • Immunology (9187)
  • Microbiology (22199)
  • Molecular Biology (8823)
  • Neuroscience (47626)
  • Paleontology (351)
  • Pathology (1431)
  • Pharmacology and Toxicology (2493)
  • Physiology (3736)
  • Plant Biology (8090)
  • Scientific Communication and Education (1438)
  • Synthetic Biology (2224)
  • Systems Biology (6042)
  • Zoology (1254)